Poor Reporting of Scientific Leadership Information in Clinical Trial Registers
Article 2008 en
Authors
MS
Melanie J. Sekeres
JG
Jennifer Gold
AC
An‐Wen Chan
Abstract
1 min read
Despite the requirements set by WHO and ICMJE, data on scientific leadership and contact e-mail addresses are frequently omitted from clinical trials registered in the two leading public clinical trial registers. To promote accountability and transparency in clinical trials research, public clinical trials registers should ensure adequate monitoring of trial registration to ensure completion of mandatory contact information fields identifying scientific leadership.
Mohsen Alayche, Kelly D. Cobey, Jeremy Y. Ng, Clare L. Ardern, Karim M. Khan, An‐Wen Chan, Ryan Chow, Mouayad Masalkhi, Ana Patricia Ayala, Sanam Ebrahimzadeh, Jason Ghossein, Ibrahim Alayche, Jessie V. Willis, David Moher
Mohsen Alayche, Kelly D. Cobey, Jeremy Y. Ng, Clare L. Ardern, Karim Khan, An‐Wen Chan, Ryan Chow, Mouayad Masalkhi, Ana Patricia Ayala, Sanam Ebrahimzadeh, Jason Ghossein, Ibrahim Alayche, Jessie V. Willis, David Moher
Gustav Nilsonne, Susanne Wieschowski, Nicholas DeVito, Maia Salholz-Hillel, Love Ahnström, Till Brückner, Katarzyna Klaś, Tarik Suljić, Samruddhi Yerunkar, Natasha Olsson, Carolina Cruz, Karolina Strzebońska, Lars Småbrekke, Mateusz T. Wasylewski, Johan Bengtsson, Martin Ringsten, Aminul Schuster, Tomasz Krawczyk, Themistoklis Paraskevas, Eero Raittio, Luca Herczeg, Jan-Ole Hesselberg, Sofia Karlsson,
Discussion(0)
No comments yet. Be the first to comment.